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บทคดัยอ่  
วตัถปุระสงค:์ เพื่อศกึษาการแสดงออกของระดบัเอม็อารเ์อน็เอและโปรตนีของ
เอชเอม็จบีวีนั (high-mobility group box-1; HMGB1) ในเซลลไ์ฟโบรบลาสตเ์อน็
ยดึปรทินัต์มนุษย ์เปรยีบเทยีบกบัเซลล์ไฟโบรบลาสต์เน้ือเยื่อในโพรงฟนัมนุษย ์
เซลล์ไฟโบรบลาสต์เหงอืกมนุษย์ และเซลล์ไลน์เคบ ีโดยเฉพาะในเซลล์ไฟโบร- 
บลาสต์เอน็ยดึปรทินัต์มนุษยท์ัง้สภาวะปกตแิละสภาวะถูกกระตุ้นด้วยไลโปโพล-ี
แซคคาไรดจ์ากเชือ้ E. coli วิธีการศึกษา: ศกึษาการแสดงออกของเอชเอม็จบีวีนั
ในระดบัเอม็อารเ์อนเอโดยวธิ ีRT-PCR ระดบัโปรตนีโดย Western analysis ใชไ้ล
โปโพลีแซคคาไรด์ในขนาด 25 และ 50 มคก./มล.ในการกระตุ้นเซลล์ไฟโบรบ
ลาสตเ์อน็ยดึปรทินัตม์นุษย ์ผลการศึกษา: พบการแสดงออกของเอชเอม็จบีวีนัใน
ระดบัเอม็อารเ์อนเอ และโปรตนีในไลเซทของเซลลท์ัง้ 4 ชนิด แต่ไมพ่บโปรตนีเอช
เอ็มจบีีวนัในอาหารเลี้ยงเซลล์ เมื่อกระตุ้นด้วยไลโปโพลีแซคคาไรด์จากเชื้อเอ
สเชอรเิชยีโคไล พบการเพิม่ระดบัของเอม็อารเ์อนเอของเอชเอม็จบีวีนั เฉพาะใน
สภาวะที่มซีีรมัของลูกววัในอาหารเลี้ยงเซลล์ แต่ไม่พบการเปลี่ยนแปลงระดบั
โปรตนีเอชเอม็จบีวีนัในเซลลไ์ลเซท แสดงวา่เมือ่เอม็อารเ์อนเอดงักล่าวเพิม่ขึน้ ไม่
สามารถผ่านต่อเป็นโปรตนีในสภาวะการทดลองน้ี สรปุ: เซลลไ์ฟโบรบลาสตเ์อน็
ยดึปรทินัต์มนุษย์ เซลล์ไฟโบรบลาสต์เน้ือเยื่อในโพรงฟนัมนุษย์ เซลล์ไฟโบรบ
ลาสต์เหงือกมนุษย์ และเซลล์ไลน์เคบี มีการแสดงออกของเอชเอ็มจีบีว ันใน
ระดบัเอม็อาร์เอนเอและโปรตนีเฉพาะในเซลล์ไลเซท แสดงว่าเอชเอม็จบีวีนัไม่มี
บทบาทเป็นโปรตนีทีห่ลัง่ออกนอกเซลลช์่องปากเหล่าน้ี การเพิม่ระดบัเอม็อารเ์อน
เอของเอชเอม็จบีวีนัในเซลลไ์ฟโบรบลาสตเ์อน็ยดึปรทินัตม์นุษยเ์ฉพาะในสภาวะที่
มซีีรมัในอาหารเลี้ยงเซลล์เมื่อได้รบัการกระตุ้นด้วยไลโปโพลแีซคคาไรด์ยนืยนั
ความสาํคญัของ LPS-binding protein ซึง่พบในซรีมั บทบาทของเอชเอม็จบีวีนัใน
โรคปรทินัตอ์กัเสบ การสง่สญัญาณของโปรตนีน้ี และบทบาทภายในเซลลข์องเอช
เอม็จบีวีนัต่อเซลลไ์ฟโบรบลาสตเ์อน็ยดึปรทินัตม์นุษยต์อ้งศกึษาต่อไป 
คาํสาํคญั: เอชเอม็จบีวีนั, ไลโปโพลแีซคคาไรด์, เซลล์ไฟโบรบลาสต์เอน็ยดึปริ
ทนัตม์นุษย ์
 
Abstract 
Objective: To investigate an in vitro mRNA and protein expression of high-
mobility group box-1 (HMGB1) in human periodontal ligament fibroblast 
(HPDLF) in comparison to human pulpal fibroblast (HPF), human gingival 
fibroblast (HGF) as well as human KB carcinoma cell line (KB). For 
HPDLF, investigation was performed in normal condition as well as after 
challenged by lipopolysaccharide from Escherichia coli (E. coli LPS). 
Method: For all four cell types, reverse transcriptase polymerase chain 
reaction (RT-PCR) was used to determine HMGB1 mRNA expression. 
Western analysis was used to detect protein expression. E. coli LPS at 25 
and 50 μg/ml was treated to HPDLF. Results: For all cell types, HMGB1 
mRNA and protein expressions in cell lysates were found, but not in 
conditioned culture media. HMGB1 mRNA was up regulated after treated 
with E. coli LPS only in the condition with fetal calf serum added. However, 
HMGB1 in HPDLF cell lysate remained unchanged indicating that the 
increased RNA expression of HMGB1 could not proceed through protein 
production in our experimental condition. Conclusion: HPDLF, HPF, HGF 
and KB cell express HMGB1 mRNA and protein only in cell lysate. This 
seems to exclude the roles of HMGB1 as a secreted protein in these oral 
cells. Up-000regulation of HMGB1 mRNA in HPDLF only in the presence of 
serum confirmed the stimulation of LPS to cell required LPS-binding protein 
presence in serum. The role of HMGB1 in periodontitis and signaling 
pathway of this protein expression, and intracellular role of HMGB1 in 
HPDLF is subject to further study. 
Keywords: high mobility group box 1 (HMGB1), lipopolysaccharide (LPS), 
human periodontal ligament fibroblasts (HPDLF)   
 
 
Introduction
High mobility group box protein 1 (HMGB1), a small 
protein of 215 residues, was first identified over 30 years 
ago.1 Previously, HMGB1 was known as a nuclear 
component with its role involving maintenance of chromatin 
structure and regulation of gene transcription.1,2 Later studies 
showed extracellular role of HMGB1 as a proinflammatory 
cytokine.3  This role has opened up a new field of research 
of HMGB1 in inflammatory diseases.  
HMGB1 can be released by some cell types. It can be 
actively released by macrophages/monocytes in response to 
stimulation with exogenous bacterial endotoxin, e.g. 
lipopolysaccharide (LPS) or endogenous proinflammatory 
cytokines, e.g. tumor necrosis factor (TNF), interleukin 1 β 
(IL-1β) and interferon gamma (IFN-γ).4-6 In addition to being 
actively released from activated innate immune cells, 
HMGB1 can also be passively released from necrotic or 
damaged cells. Once released, HMGB1 is able to alert other 
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cells involved in the immune response or inflammatory 
reaction. Therefore, HMGB1 might be a critical molecule that 
allows innate immune cells both to respond to injury, and to 
further induce inflammatory reaction. HMGB1 has been 
termed as a late mediator of endotoxin lethality, because its 
releasing is delayed by several hours compared with other 
proinflammatory cytokines that mediate shock and tissue 
injury.7 The cytokine activity of HMGB1 has been well-
documented in many cell types and tissues such as 
macrophages/monocytes, endothelial cells, neutrophils, 
epithelial cells, dendritic cells, smooth muscle cells, brain, 
lung, joint, etc.8 However, most cells including lymphocytes, 
adrenal or kidney cells, are unable to secrete HMGB1.4  
HMGB1 has an important role in several acute and 
chronic inflammatory diseases such as sepsis, acute lung 
injury and arthritis.9 Periodontitis is an infectious disease that 
leads to inflammation of the gingiva and destruction of 
periodontal tissues.9 Oral microbes are associated in the 
initiation and progression of periodontal disease that 
eventually cause tooth loss. Gram negative bacteria have 
become widely recognized as the periodontopathic 
bacteria.10 The bacteria are capable of producing virulent 
substances that directly cause periodontal tissue breakdown 
and alveolar bone resorption.11  
LPS, a component of the bacterial outer membrane, is 
the pathogenic factor in a wide variety of periodontopathic 
bacteria. The LPS molecule consists of three parts: LIPID A, 
core polysaccharide, and O-specific chains (O antigens). 
When periodontopathic bacteria proliferate in periodontal 
pockets, it is suggested that LPS is released, causing 
resident fibroblasts as well as immune cells to synthesize 
inflammatory cytokines including IL-1, IL-6 and TNF-α.12 
These cytokines, in turn, aggravate inflammation, destroy 
periodontal tissues, and induce alveolar bone resorption.13,14 
When derived from Escherichia Coli (E. Coli ), LPS serves as 
polyclonal B-cell mitogens commonly used in immunology 
laboratory. Treatment of mice with LPS which causes liver 
injury induces a threefold increase of HMGB1 protein in liver 
within 1 - 2 hours.15  
There had been some studies regarding HMGB1 roles in 
oral diseases. Morimoto et al (2006) showed expression of 
HMGB1 in gingival epithelium of patients with periodontitis 
as well as human gingival carcinoma cell line in vitro.16 
Feghali et al showed expression of HMGB1 in human 
gingival fibroblast (HGF) and its released after stimulation 
with periodontopathic bacteria LPS.17 Our present study 
aimed to characterize the mRNA and protein expression 
profile of HMGB1 in primary human periodontal ligament 
fibroblast (HPDLF) under normal condition and after 
stimulation by E. coli LPS. The findings from this study could 
help understand more on the biologic basis of periodontal 
pathogenesis, which might lead to new strategies for the 
treatment of periodontitis.  
 
Materials and Method 
Cell culture and activation by LPS 
Human periodontal ligament fibroblasts (HPDLF), human 
gingival fibroblasts (HGF) and human pulpal fibroblasts 
(HPF) were cultured from the explants obtained from the 
non-carious, freshly extracted third molars, or teeth removed 
for orthodontic reason with informed consent. The 
periodontal ligament (PDL) was scraped from the middle 
third of the root. Pulpal tissue was obtained from the pulp 
chamber after separated the tooth. Gingival tissue was 
obtained from healthy gingiva attached to extracted tooth 
which was removed for orthodontic reason. At least 2 sets 
for each tissue were used in this study. All of the tissue were 
washed with sterile phosphate buffer saline (PBS) and cut 
into small pieces, then plated into 60-mm tissue cultured 
plates (Nunc, Napervile, IL, USA). All explants as well as KB 
cells line (originally from ATCC  NO.CCL-17: oral epidermal 
carcinoma cell) were grown in Dulbecco’s Modified Eagle 
Medium (DMEM) supplemented with 5% fetal calf serum 
(5%FCS-DMEM), 2mM L-glutamine, 100 units/ml penicillin 
and 100 μg/ml streptomycin at 37 °C in humidified 
atmosphere of 5% CO2. Media and the supplements were 
from Gibco BRL (Carlsbad, CA, USA). Cells from the third to 
eighth passages were used in this study. Lipopolysaccharide 
(LPS) from E.Coli (0111:B4 serotype) (Sigma) was dissolved 
in distilled water and its stock was prepared at 10 μM. 
Cells were seeded in 6-well plates (2x105 cells/well) 
(Nunc, Napervile, IL, USA) or in 96-well plates (15,000 
cells/well) in 5% FCS–DMEM and allowed to attach 
overnight. After attachment, cells were washed 3 times with 
DMEM and media changed to serum free DMEM (SF-
DMEM) as well as 2.5% fetal calf serum (2.5%FCS-DMEM). 
In LPS treatment group, LPS was added to a final 
concentration of 25 μg/ml and 50 μg/ml and sterile distilled 
water was used as a control. Durations of LPS treatment 
were 24 hours for RNA extraction, and 48 and 72 hours for 
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cell lysate extraction and conditioned media collection 
respectively. The experiments were performed twice with 
duplication in each experiment. To determine HMGB1 
expression, total RNA analysis was performed by reverse- 
transcriptase polymerase chain reaction (RT-PCR) and 
protein analysis was investigated both in cell lysate and 
cultured media by Western analysis.  
 
The determination of HMGB1 expression by RT-PCR 
Total RNA was extracted using TRIzol reagent (Life 
Technologies), as recommended by the manufacturer. 
Briefly, 1 ml of TRIzol reagent was added to each well for 5 
minutes. Then 200 μl of chloroform were added and 
centrifuged at 10,000 rpm, 4 °C, for 15 min. The upper 
aqueous part was collected, 500 μl of isopropanol was then 
added and centrifuge at 10,000 rpm, 4 °C, for 10 min. The 
cell pellet was collected and washed with 75% ethanol, 
mixed and spun down. The pellet was air dried at room 
temperature. Total RNA was dissolved by adding 15 μl of 
RNase-free water, warmed at 55 °C for 10 min. and stored 
at -70 °C until used.  
First strand cDNA was generated according to 
RevertAidTM first strand cDNA synthesis kit (Fermentas, Life 
Sciences, USA). The RNA was first DNase-treated in a 20 μl 
reaction containing 10 μl of RNA, 2 μl PCR buffer, 10 U 
DNase, and 40 U RNase inhibitor. Reverse transcription was 
conducted in a 25 μl reaction of 2 μg of DNase-treated RNA, 
0.5 μg of oligo d(T) 12-18 and DEPC-treated water. The 
reaction was heated to 70 °C for 10 mins then chilled on ice 
for 5 min. The content of 5X reaction buffer, 40 U of 
ribonuclease inhibitor and dNTP was added into the mixture 
and incubated at 37 °C for 5 min. before the addition of 1 μl 
of RevertAidTM M-MuLV reverse transcriptase. The mixture 
was mixed and incubated at 42 °C for 1 hour. The mixture 
was then collected and stored at -20 °C until used. 
HMGB1 primers were synthesized by OPERON 
(Qiagen). The sequence of primers was determined using 
the clustalx 1.6b. Primer’s length was between 18 and 25 
bases and melting temperature ™ was between 50 and 
65 °C (Oligo v.3.4). To determine specificity, all sequences 
were compared with the Genbank using the program Blast 
available at the National Center for Biotechnology 
Information website (www.ncbi.nlm.nih.gov). The 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was 
used as an internal control. 
The sequences of primers are as follows:  
HMGB1:  Forward; 5’-CTCTTCTGCTCTGAGTATCGC-3’  
                              Reverse; 5’-CAACTGAAGATGAAAAAACTACC-3’  
GAPDH:   Forward; 5’-TGAAGGTCGGAGTCAACGGAT-3’  
                 Reverse 5’-TCACACCCATGACGAACATGG-3’.  
 
The PCR was performed using Taq polymerase with a 
PCR volume of 25 μl. The mixtures contained 10 pg – 1 μg 
of cDNA template, 0.2 mM of each of dNTPs, 10x PCR 
buffer, MgCl2 concentration between 1 - 5 mM, 0.6 U of Taq 
DNA polymerase, 0.2 - 0.3 μM of HMGB1 and GAPDH 
primers. The PCR working conditions were set for initial 
activation at 95 °C, for 5 min., a denaturation at 94 °C, for 
15 sec, primer annealing at 53 °C for 1 min, chain elongation 
at 72 °C for 1 min. and final extension at 72 °C for 10 min.  
on a DNA thermal cycler (ICycler, BioRad). The amplified 
DNA was proceeded to electrophoresis on a 1.6% agarose 
gel and visualized by ethidium bromide staining.  
 
HMGB1 protein determination by Western analysis 
Conditioned media were collected and spun down to 
remove cell debris. Supernatant was kept for extracellular 
protein measurement. Cells were washed with PBS and 
protein extracted by 100 μl of 1% SDS for cell lysate 
analysis. The total proteins were measured by Bradford 
reagent. All samples were fractionated by 10% SDS-PAGE. 
Equal amount of sample loadings were calibrated based on 
amount of total protein in cell lysate. The proteins were then 
transferred to a (poly) vinylidene difluoride immunoblot 
membrane (PVDF) (Bio-Rad Laboratories, Hercules, CA). 
The membrane was blocked for 1 hour with blocking solution 
(5% skim milk in TBS-T) and then incubated with HMGB1 
antibodies (Monoclonal Anti-HMG-1 Clone HAP46.5, Sigma, 
USA) for 1 hour, at 1:1,000 dilution. The membrane was 
washed for 10 min. 5 times in washing solution and then 
incubated with ECL Anti-Mouse IgG, Horseradish 
Peroxidase-Linked Species-Specific whole Antibody (from 
sheep) (Amersham Bioscience, UK) as the secondary 
antibody, 1:50,000 dilution  for 1 hour at room temperature. 
Signals were developed with an enhanced 
chemiluminescence kit (ECL plus) (Amersham Pharmacia 
Biotech) according to manufacturer’s protocol. For detection 
of the chemiluminescent signal, the membrane should be 
exposed to standard HyperfilmTM ECL (Amersham 
Bioscience, UK). The several exposures may be required in 
order to generate the appropriate signal strength.   
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Results 
 
Expression of HMGB1 in HPDLF, HPF, HGF and KB 
cell line  
HMGB1 RNA, protein expression in HPDLF and their 
responses by LPS activation were investigated in this study. 
It was of interest to determine the expression of HMGB1 in 
primary HPDLF compared to other oral cells including 
primary HPF, HGF as well as KB cell line. We performed 
RT-PCR and western analysis for RNA and protein 
detection, respectively. It was found that all cells expressed 
HMGB1 mRNA (Figure 1A) as well as HMGB1 protein in cell 
lysate (Fig. 1B). HMGB1 was not found in conditioned media 
for all cell types in this study (data not shown).  
 
Figure 1 Expression of HMGB1 in various oral fibroblasts and 
KB cells.  
Note: Cells (2x105 cells/well) were plated in a 6-well plate. After 
attachment, media were changed to DMEM with 2.5% FCS. At 24 
and 48 hours, RNA and cell lysate were collected respectively. 
HMGB1 RNAs were shown by RT-PCR along with GAPDH (1A). The 
levels of cellular HMGB1 contained in the cell lysate were determined 
by Western analysis of the cell lysate (1B). 
 
HMGB1 RNA expression after LPS activation 
In this study E. coli LPS was used to induce HPDLF 
injury. Previous study suggested that activation by LPS 
required specific plasma protein such as LPS-binding protein 
(LBP) in order to mediate attachment to receptors on cells.18 
Thus, we treated HPDLF with E. coli LPS in both serum-free 
and in 2.5% FCS media condition.  
After 24-hour incubation, expression of HMGB1 RNA by 
semi-quantitative RT-PCR was analyzed. GAPDH as a 
house keeping gene was used for an internal control. 
Appropriate cycle number was initially tested and cycle 24 
was selected as it had started to show HMGB1 expression in 
LPS treated group but not in a control group (Fig. 2A). 
However, this up-regulation only occurred in a condition with 
2.5% FCS but not in a serum free condition, confirming the 
requirement of LPS on LPS-binding protein (LBP) presence 
in serum.18,19 In SF-DMEM, HMGB1 expression started to 
show around cycle 26 and there was no difference in levels 
between the control and LPS-treated group even when we 
delayed the PCR cycle to 30 (figure 2B.). The data here 
suggested that the expression of HMGB1 RNA in HPDLF 
has been up-regulated by 25 and 50 μg/ml of LPS, only in 
2.5% FCS-DMEM condition. 
 
2A. 
 
 
- 680 bp HMGB1 
 
 
 
- 390 bp GAPDH 
          Control                      LPS 25                 LPS 50  
   
2B. 
 
 
- 680 bp HMGB1 
 
 
 
 
- 390 bp GAPDH 
               Control                           LPS 50       
Figure 2 Up regulation of HMGB1 RNA after LPS treatment.  
Note: HPDLF (2x105 cells/well) were plated in a 6-well plate and 
treated with 25 and 50 μg/ml of E. coli LPS in 2.5% FCS-DMEM (2A) 
and SF-DMEM (2B) for 24 hours. Sterile dH2O was used as a control. 
After 24-hr RNA extraction, RT-PCR was performed to analyze 
HMGB1 (680 bp) and GAPDH (390 bp), internal control. Only in 
media with 2.5% FCS that up regulation of HMGB1 RNA could be 
seen (cycle 24 for 2A. and cycle 30 for 2B.). 
 
HMGB1 protein expression and secretion after LPS 
activation  
In this study HMGB1 protein expression in HPDLF, both 
in cell lysate and in conditioned media, was investigated. It 
was found that cellular HMGB1 was unchanged after LPS 
treatment for 48 - 72 hours, as shown in Fig. 3A and 3B. 
HMGB1 secretion in conditioned media also was 
investigated since there are studies showing induction of 
HMGB1 secretion with LPS, IL-1 and TNF-α stimulation in 
some cell types.4-6 However, after 48-, 72- and 96-hour LPS 
treatment to HPDLF, HMGB1 was still undetectable in 
conditioned media as shown in Fig. 3C for a 96-hour 
incubation.  
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LPS treatment.4 However, they found increased cellular and 
extracellular HMGB1 protein in macrophages. Sass et al 
demonstrated up regulation of HMGB1 protein after LPS 
treatment in liver of experimental mice.15 Feghali et al 
showed LPS from Aggregatibacter actinomyctemcomitans 
and Porphyromonas gingivalis induced HMGB1 secretion 
from HGF.17 However, they could not detect any changes in 
HMGB1 mRNA levels. The mechanism of HMGB1 induction 
seems complicate and requires further clarification. The 
difference might be partly due to cell types. However, the 
results from our present study suggested periodontal 
ligament cells might not be a source of secreted HMGB1. 
Another interesting work by Hertal et al found that decreased 
expression of HMG protein T160 by antisense RNA impaired 
growth in mouse fibroblasts.29 As HMGB1 has long been 
known as a nuclear protein in almost all mammalian cells 
and many evidences suggested its involvement in a basic 
cell function, e.g. DNA replication.30,31 An up-regulation of its 
mRNA might suggest its intracellular role which needs 
further investigation. 
 
Conclusion 
This study found primary oral fibroblasts and KB cell line 
to contain HMGB1 RNA and cellular protein, but they are 
unable to secrete HMGB1. In the presence of serum, LPS is 
able to up-regulate HMGB1 transcription but not protein 
production in HPDLF. The role of HMGB1 in periodontitis is 
still unclear and requires further investigation. The LPS-
induced increase in HMGB1 protein was markedly smaller 
than the increment in HMGB1 RNA. The reason for this 
apparent discrepancy between RNA and protein levels for 
HMGB1 is not known. Further investigation is required for an 
interesting intracellular role of HMGB1 to some basic cell 
function of HPDLF, rather than in its secreted form.  
 
References 
1. Goodwin GH, Sanders C, Johns EW. A new group of chromatin-
associated proteins with a high content of acidic and basic amino 
acids. Eur J Biochem 1973;38:14-19. 
2. Agresti A, Bianchi ME. HMGB proteins and gene expression. Curr Op 
Genet Develop 2003;13:170–178. 
3. Wang H, Yang H, Tracey KJ. Extracellular role of HMGB1 in 
inflammation and sepsis. J Intern Med 2004;255:320-331. 
4. Wang H, Bloom M, Zag JD, et al. HMG-1 as a late mediator of 
endotoxin lethality in mice. Science 1999;285:248-251. 
5. Wang H, Vishnubhakat JM, Bloom O et al. Proinflammatory cytokines 
(tumor necrosis factor and interleukin 1) stimulate release of high 
mobility group protein-1 by pituicytes. Surgery 1999;126:389-392. 
6. Rendon-Mitchell B, Ochani M, Li J, et al. IFN-gamma induces high 
mobility group box1 protein release partly through a TNF-dependent 
mechanism. J Immunol 2003;170:3890-3897. 
7. Scaffidei P, Misteli T, Bianchi ME. Release of chromatin protein 
HMGB1 by necrotic cells triggers inflammation. Nature 2002;418:191-
195. 
8. Page RC, Schroeder HE. Current status of the host response in 
chronic marginal periodontitis. J Periodontol 1981;52:477-491. 
9. Page RC. Gingivitis. J Clin Periodontol 1986;13:345-359. 
10. Haeffner-Cavaillon N, Caroff M, Cavaillon JM. Interleukin-1 induction 
by lipopolysaccharides: structural requirements of the 3-deoxy-D-
manno-2-octulosonic acid (KDO). Mol Immunol 1989;26:285-294. 
11. Nishihara T, Koseki T. Microbial etiology of periodontitis. Periodontol 
2000 2004;36:14-26. 
12. Yamaji Y, Kuboto T, Sasaguri K, et al. Inflammatory cytokine gene 
expression in human periodontal ligament fibroblasts stimulated with 
bacterial lipopolysaccharide. Infect Immun 1995;3576-3589. 
13. Takashiba S, Naruishi K, Murayama Y. Perspective of cytokine 
regulation for periodontal treatment: fibroblast biology. J Periodontol 
2003;74:103-110. 
14. Rietschel ET, Kirikae T, Schade FU, et al. Bacterial endotoxin: 
Molecular relationships of structure to activity and function. FASEB J 
1994;8:217-225. 
15. Sass G, Heinlein S, Agli A, Bang R, Schumann J, Tiegs G. Cytokine 
expression in three mouse models of experimental hepatitis. Cytokine 
2002;19(3):115-120. 
16. Morimoto Y, Kawahara K, Tancharoen S, et al. Tumor necrosis 
factor-alpha stimulates gingival epithelial cells to release high 
mobility-group box 1. J Periodont Res 2008;43:76-83. 
17. Feghali K, Iwasaki K, Tanaka K, et al. Human gingival fibroblasts 
release high-mobility group box-1 protein through active and passive 
pathways. Oral Microbiol Immun 2009;24:292-298. 
18. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, 
a receptor for complexes of lipopolysaccharide (LPS) and LPS 
binding protein. Science 1990;249:1431-1433.  
19. Schumann RR, Leong SR, Flaggs GW, et al. Structure and function 
of lipopolysaccharide binding protein. Science 1990;249(4975):1429-
1431. 
20. Offenbacher S. Periodontal disease pathogenesis. Ann Periodontol 
1996;1:821-878. 
21. Gardella S, Andrel C, Ferrera D, et al. The nuclear protein HMGB1 is 
secreted by monocytes via a non-classical, vesicle-mediated 
secretory pathway. EMBO Rep 2002;3:995-1001. 
22. Degryse B, Bonaldi T, Scaffidi P, et al. The high mobility group 
(HMG) boxes of the nuclear protein HMG1 induce chemotaxis and 
cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol 
2001;152:1197-2006. 
23. Landsman D, Bustin M. A signature for the HMG-1 box DNA-binding 
proteins. Bioessays 1993;15:539- 546. 
24. Taniguchi N, Kawahara K, Yone K, Hashiguchi M, Goto M. High 
mobility group box chromosomal protein 1 plays a role in the 
ไทยเภสชัศาสตรแ์ละวทิยาการสขุภาพ ปี 6 ฉบับ 3, กค. – กย. 2554 181  Thai Pharm Health Sci J Vol. 6 No. 3, Jul. – Sep. 2011 
pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis 
Rheum 2003;48:971-981. 
25. Fiuza C, Bustin M, Talwar S, et al., Inflammatory promoting activity of 
HMGB1 on human microvascular endothelial cells. Blood 2003;101: 
2652-2660. 
26. Lum HK, Lee KLD. The human HMGB1 promoter is modulated by a 
silencer and an enhancer-containing intron. Biochimica et Biophysica 
Acta (BBA)/ Gene Structure and Expression 2001;1520(1):79-84. 
27. Muller S, Ronfani L, Bianchi ME. Regulated expression and 
subcellular localization of HMGB1, a chromatin protein with a cytokine 
function. J Intern Med 2004;255(3):332-343. 
28. Grasser KD and Feix G. Isolation and characterization of maize 
cDNAs encoding a high mobility group protein displaying a HMG-box. 
Nucleic Acids Res 1991;19(10):2573-2577.  
29. Hertel L, Foresta P, Barbiero G, et al. Decreased expression of the 
high-mobility group protein T160 by antisense RNA impairs the 
growth of mouse fibroblasts. Biochimie 1997;79:717-723. 
30. Bustin M. Regulation of DNA-dependent activities by the functional 
motifs of the high mobility group chromosomal proteins. Mol Cell Biol 
1999;19:5237-5246. 
31. Mosevitsky MI, Novitskaya VA, Iogannsen MG, Zabezhinsky MA. 
Tissue specificity of nucleo-cytoplasmic distribution of HMG1 and 
HMG2 proteins and their probable functions. Eur J Biochem 1989; 
185:303-310.   
 
Editorial note 
Manuscript received in original form on May 2, 2011  
accepted in final form on August 1, 2011 
